Search results
Results from the WOW.Com Content Network
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. [1] [2] A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. [3]
The Philippines is considering re-introducing a dengue vaccine whose use it halted because of links to the deaths of several children, as authorities battle to contain a dengue outbreak that has ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
The World Health Organization has prequalified a new dengue vaccine recommended for use in children in areas where mosquito transmission to humans is high.
Last week WHO reported there were 6.7 million suspected cases of dengue in the Americas, an increase of 206% compared with the same period in 2023. In March, authorities in Rio de Janeiro declared a public health emergency over its dengue epidemic and the country began rolling out the Takeda vaccine, aiming to inoculate at least 3 million ...
Flu vaccines used during the flu in 2009. This is a list of vaccine-related topics.. A vaccine is a biological preparation that improves immunity to a particular disease.A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins.
Story at a glance Dengue virus is transmitted to humans through mosquito bites. It can cause severe illness and death. A new vaccine candidate was more than 83 percent effective at protecting ...
The Department of Health (DOH) of the Philippines declared a measles outbreak in Metro Manila due to a 550% increase in the number of patients from January 1 to February 6, 2019, compared to figures of the equivalent period from 2018. [1] Outbreaks were also officially declared in Central Luzon, Calabarzon, Western Visayas, Central Visayas.